In December of 2018, the Farm Bill was established legalizing hemp. Legal hemp is defined as containing less than .3% THC, or tetrahydrocannabinol. CBD has been flourishing in the economy since the legalization of hemp and its derivatives. However, the FDA has yet to make any sound decisions on the limitations set around the cannabis derivative. There has been a lot of dispute and confusion all over the country. Just recently, a Florida judge put a case on hold regarding CBD. They are leaving this case on hold until the FDA can make a clear limitation around CBD and whether or not laws were indeed broken.
Confusion Causing Problems
There are currently hundreds of companies facing lawsuits and liability claims due to labeling around CBD products. Due to the FDA stating that CBD cannot be labeled as a medical supplement, people are getting in trouble over the products. Distribution is still more than allowed and certain areas CBD is being promoted and approved across the board. This situation where U.S. District Judge Ursula Ungaro ruled that the case be put on hold until the FDA makes a clear statement over the legality of labeling will not be the last. Plenty of other companies were not this lucky over the matter and are being punished over something that hasn’t been proven to be bad.
FDA Needs to Focus and Find Results!
Until there are actual limitations set for CBD such as labeling and food regulatory laws, these issues will continue to show up. People are trying to experiment with this cannabis derived compound that brings benefits for so many others. With all the legality loopholes, people are getting put on hold over a decision that could take well over a year for the Food and Drug Administration to make. All we truly need is some regulatory oversight from the FDA and some type of limitation system. Until then, be careful where you go for your CBD products.